Comparison of Performance and Cost-Effectiveness of Direct Fluorescent-Antibody, Ligase Chain Reaction, and PCR Assays for Verification of Chlamydial Enzyme Immunoassay Results for Populations with a Low to Moderate Prevalence of Chlamydia trachomatis Infection

Many laboratories use a commercial enzyme immunoassay (EIA) with verification testing to diagnose Chlamydia trachomatis infections in an effort to contain costs. This study was designed to compare the performance and cost-effectiveness of direct fluorescent-antibody assay (DFA), commercial PCR, and...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Microbiol
Principais autores:	Dean, Deborah, Ferrero, Dennis, McCarthy, Michael
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Chlamydiology and Rickettsiology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC124815/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9431928/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.36.1.94-99.1998
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!